Rating History for BioXcel Therapeutics (BTAI) by Rodman & Renshaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/17/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
17.00 (N/A) |
1.54 (0.89) |
-42.21% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/17/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
17.00 (N/A) |
1.54 (0.89) |
-42.21% | Details |
![]() |
|||||||